Cargando…
PPAD: A deep learning architecture to predict progression of Alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disease that affects millions of people worldwide. Mild cognitive impairment (MCI) is an intermediary stage between cognitively normal (CN) state and AD. Not all people who have MCI convert to AD. The diagnosis of AD is made after significant symptoms...
Autores principales: | Al Olaimat, Mohammad, Martinez, Jared, Saeed, Fahad, Bozdag, Serdar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915480/ https://www.ncbi.nlm.nih.gov/pubmed/36778453 http://dx.doi.org/10.1101/2023.01.28.526045 |
Ejemplares similares
-
PPAD: a deep learning architecture to predict progression of Alzheimer’s disease
por: Al Olaimat, Mohammad, et al.
Publicado: (2023) -
Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis
por: Castellar-Mendoza, Camilo, et al.
Publicado: (2023) -
Citrullination mediated by PPAD constrains biofilm formation in P. gingivalis strain 381
por: Vermilyea, Danielle M., et al.
Publicado: (2019) -
TLR2 Activation by Porphyromonas gingivalis Requires Both PPAD Activity and Fimbriae
por: Wielento, Aleksandra, et al.
Publicado: (2022) -
The P2 Receptor Antagonist PPADS Supports Recovery from Experimental
Stroke In Vivo
por: Lämmer, Alexandra B., et al.
Publicado: (2011)